Table 2. Verification phase maximal responses.
|
CPET |
GKT |
p-value (ES) |
| VER |
∆% |
VER |
∆% |
Test p |
Phase p |
T*P p |
Maximal Oxygen Uptake
(mL·kg-1·min-1) |
58.1 (4.2) |
-0.2 (7.1) |
55.6 (6.1) |
-0.1 (10.1) |
0.13 (0.56) |
0.22 (0.44) |
0.36 (0.32) |
| Maximal Heart Rate (beats·min-1) |
188(9) |
-2.1 (2.2) |
190(6) |
-1.2 (1.1) |
1.00 (0.00) |
0.002* (1.41) |
0.18 (0.48) |
Maximal Respiratory
Exchange Ratio (V̇CO2/V̇O2) |
1.02 (0.07) |
-12.9 (9.3) |
0.97 (0.06) |
-20.5 (9.2) |
0.64 (0.16) |
<0.001* (2.21) |
0.03* (0.83) |
| Maximal Expired Minute Ventilation (L·min-1) |
124.1 (15.2) |
-2.6 (11.0) |
127.5 (17.1) |
-3.0 (7.3) |
0.35 (0.33) |
0.17 (0.50) |
0.93 (0.03) |
Verification Phase
Duration (s) NP |
96(38) |
- |
94(45) |
- |
0.06 (0.60) |
- |
- |
Parametric data presented as mean (standard deviation) and non-parametric (
NP) data presented as median (interquartile range). Physiological outcomes compared with Two-way repeated measures ANOVA. Verification Phase Duration was compared with Wilcoxon Test. CPET - Running Cardiopulmonary Exercise Test. GKT – Graded Karate Test. VER – Verification Phase. ∆% - Percentage difference of Verification phase and Incremental maximal outcomes [(Incremental-Verification)/Incremental]. ES – Effect size (Cohen’s f for physiological outcomes and r (Z√n) for verification phase duration). * denotes significant difference (p ≤ 0.05). T*P – Test and phase interaction.
